Frederick Godley is an ENT-otolaryngologist and the co-founder and current president of the Association of Migraine Disorders, a not-for-profit organization. He graduated from the Boston University School of Medicine in 1983, and completed his general surgical residency at the University of Massachusetts Medical Center. His specialty training was at the Yale New Haven Hospital. In keeping with the spirit of both giving to and learning from others, he has taught young surgeons at the Johns Hopkins Hospital, the Massachusetts Eye & Ear Infirmary, and the Rhode Island Hospital. He works in Providence, Rhode Island, specializing in Otolaryngology and Pediatric Otolaryngology.
John Meitzen is a professor in the Department of Biological Sciences at North Carolina State University. His laboratory investigates how steroid sex hormones modulate neuron electrophysiology, with a particular emphasis on estradiol and the striatum. He was honored in 2016 by SfN with the Next Generation Award. Meitzen received his Ph.D. in neurobiology and behavior from the University of Washington, completed his postdoctoral training at the University of Minnesota, and was a Grass Fellow at the Marine Biological Laboratory.
Mary Angela O'Neal is a Chief of General Neurology at Brigham and Women's Hospital. She graduated from Oregon Health Sciences University School of Medicine. She previously worked at Boston University, Carney Hospital, and South Shore Hospital. She obtained her Board Certification from the American Board of Psychiatry and Neurology. Her specialties are Neurology and Women's Health. Her clinical interests are in the field of general neurology, functional neurological disorders, and stroke.
Nina Riggins, MD, PhD, FAAN, FAHS is a board certified Neurologist and UCNS certified Headache Specialist. Dr Riggins is a President and CEO of the Brain Performance Center and Research Institute, she is a Director of the Headache center of The Neuron Clinic, San Diego, California. Dr Riggins completed her Internal Medicine internship at Texas Tech University, and her neurology residency at Penn State Medical Center. Dr Riggins completed her clinical neurophysiology fellowship at the State University of New York, Buffalo and headache medicine fellowship at the University California, San Francisco. Dr Riggins is a Vice Chair of the American Academy of Neurology Headache & Facial pain section and a Vice Chair of the First Contact Program of American Headache Society. She is devoted to working together with her patients and colleagues to improve brain health and relieve pain. Dr Riggins is a Board member of Miles for Migraine and a Vice Chair of the BrainPAC, AAN. She is a member of the UCNS exam committee. She is a Social Media Editor for Cephalalgia and Cephalalgia Reports, Journals of the International Headache Society.
Nanette Santoro completed her medical training in the 6-year B.S.-M.D. program at Rensselaer Polytechnic Institute and Albany Medical College, followed by residency at Beth Israel Medical Center in New York City and a fellowship in Reproductive Endocrinology at Massachusetts General Hospital, where she remained on faculty for 3 years before joining the faculty at New Jersey Medical School in 1988. She helped recruit talent to make the University of Colorado’s Department of OB/GYN #8 in the country for NIH funding in 2017. Throughout her career thus far, she has personally mentored over 100 students, residents, postdoctoral fellows, and junior faculty, many of whom have gone on to illustrious academic careers. She is the past Chair of the Steering Committee for the Reproductive Medicine Network and current principal investigator with the CONFIRM network, both NIH-funded clinical trial networks devoted to the study of problems in human reproduction. Additionally, she has held leadership positions within numerous professional organizations, and is currently President-Elect of the Society for Reproductive Investigation. Among the achievements of her decorated career, she was elected to the National Academy of Medicine in 2018. She has been named a Castle Connelly “Best Doctor” and “Best Doctor in America”, as well as a “Best Doctor” by New York Magazine and “Top Doc” by 5280 Magazine.
Dr. David Yeomans is an associate professor of anesthesiology, perioperative, and pain medicine at Stanford University, Palo Alto, CA, USA. He earned, from Dartmouth College, an AB in Psychology (1979), and a Ph.D. from The University of Florida in Neuroscience (1989). He is both a member of the Bio-X and Wu Tsai Neurosciences Institute. He has published 113 papers with 4582 citations and an h-index of 41 (Scopus, 26 December 2023). His research topics mainly include: Intrathecal, Drug, and Delivery.
Lars Edvinsson is a Professor and senior consultant at Lund University/Hospital in Internal Medicine, MD, PhD, Chairman of the Swedish Migraine Society on the board of EHF, and immediate past president of IHS. He was invited to be a professor at Copenhagen University in "Receptor Regulation in Cerebrovascular and Cardiovascular Diseases" in 2008, and is currently Director of the Glostrup Research Park, Copenhagen. In 2012, he received a Lifetime Achievement award from American Headache colleagues (Stowe, VT) and Honorary Dr Hon Causa in Szeged, Hungary. He has a long history in studies of cerebral circulation, innervation, receptors, and function. In 1984, he was the first to describe CGRP in cranial vessels and the trigeminal ganglion, showed the release of CGRP in conjunction with migraine and cluster headache attacks, and has been instrumental in the development of novel CGRP receptor antagonists. His current work is centered on finding the localization of the CGRP family of receptors in cranial structures and CNS to illustrate the possible sites of action of novel CGRP-acting drugs. The work also involves studies of other possible migraine candidates such as PACAP and 5-HT subtype receptor expressions, as well as studies of their interactions and functional roles.
